Collegium Pharmaceutical Inc. (United States) is listed on the Nasdaq and has a market capitalization of $793.28 million, with shareholders equity totaling $296.44 million.
The company employs approximately 234 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Collegium Pharmaceutical Inc. reported $815.19 million in revenue, generating net income of $38.17 million.
Key financial metrics include a P/E ratio of 20.78, a price-to-book (P/B) ratio of 2.68, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker COLL.